SELLAS Life Sciences Group financial statements

셀라스 라이프 사이언시스 그룹NASDAQ:SLS · Nasdaq · Healthcare · sector #17
$11.31-0.26%
2026-10-07 close

SELLAS Life Sciences Group's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$32M.

Reported results

SELLAS Life Sciences Group notifications

Quantus Signal · live data · not investment advice · Privacy Policy